Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 62135-508

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 62135-508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab 10mg Bottle Label)

Label for Oxybutynin Chloride extended-release tablets USP, 10 mg strength, oral dosage form. The package contains 90 tablets and is labeled Rx Only. The product is manufactured by Chartwell RX, LLC. The label includes dosing and storage information, a UPC barcode, and the statement 'No Varnish' on the side.*

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab 15mg Bottle Label)

Label of Oxybutynin Chloride extended-release tablets USP, 15 mg strength, oral dosage form. The package contains 90 tablets and is labeled Rx only. Manufactured by Chartwell RX, LLC. The label includes dosage instructions, storage conditions, and a barcode.*

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab 5mg Bottle Label)

Label for oxybutynin chloride extended-release tablets USP, 5 mg strength, oral dosage form. The label indicates a package of 90 tablets and is marked Rx Only. The labeler is Chartwell Rx, LLC. The design includes a blue section highlighting the 5 mg strength and contains storage and dosing information along the side.*

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab Chemical Structure)

Chemical structure of oxybutynin chloride, showing its molecular components including a cyclohexyl group, benzene ring, ester linkage, and diethylamino group with a hydrochloride salt.*

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab Figure 1)

A line graph showing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours with time (hours) on the x-axis. It compares oxybutynin chloride extended-release tablets 10 mg once daily (QD) and oxybutynin 5 mg three times daily (TID) with data points and error bars for concentration variability.*

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab Figure 2)

A line graph showing the mean plasma concentration of R-Oxybutynin over time in hours. The y-axis is labeled with concentration in ng/mL, ranging from 0.0 to 2.0, and the x-axis is labeled with time in hours from 0 to 24. Data points with error bars indicate mean concentration values at various time intervals up to 24 hours.*

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab Figure 3)

A horizontal bar chart comparing the mean change in episodes per week from baseline for oxybutynin chloride extended-release tablets versus placebo. The x-axis represents mean change with a scale from -40 to 40, and data are shown with standard deviation error bars.*

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab Figure 4)

A horizontal bar chart comparing the mean change with standard deviation in episodes per week from baseline between oxybutynin chloride extended-release tablets and placebo. The x-axis ranges from -40 to 40, showing differences in treatment effect.*

FDA Label Image

Image Description (Oxybutynin Chloride Er Tab Figure 5)

A horizontal bar chart showing mean change (±SD) in episodes per week from baseline for oxybutynin chloride extended-release tablets and oxybutynin. The x-axis ranges from -40 to 40 mean change in episodes per week. Two horizontal bars represent the reduction in episodes from baseline, one for oxybutynin chloride extended-release tablets and one for oxybutynin, with the extended-release tablets showing a greater reduction.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.